Poster Library

POSTER LIBRARY

Use the links below to download posters from our international meetings.

FALL SUMMIT 2021

‘Real-world’ Canadian experience of pomalidomide plus dexamethasone for relapsed and refractory multiple myeloma

Approval of Oral Oncolytics: 1995-2020

Clinical and cost impact of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and the alternative ARTA (abiraterone or enzalutamide)

Cannabinoids: General Uses and Interactions

Clinical outcomes of SARS-COV-2 on cancer patients and treatment options

Dose Rounding Initiative at CSNF Working

REAL-WORLD BURDEN OF MYELOSUPPRESSION AMONG PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER TREATED IN THE COMMUNITY ONCOLOGY SETTING

Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia: Up to 7 Years of Follow-Up From the RESONATE-2 Study

Daratumumab Dosing Analysis Among Patients with Multiple Myeloma in a US Community Oncology Setting: A Retrospective Observational Study in the Integra Connect Network

Guideline and standard development for medically integrated dispensing pharmacies for oral anticancer medication: ASCO/NCODA standards

Management of Immunotherapy Related Rash

Managing PI3K Inhibitor- Associated Hyperglycemia: Updates From the SOLAR-1 Trial

Potential Cost Savings from Dose Rounding

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool: An Online Method of Identifying and Preventing Drug Waste

Expansion Analysis of a Grassroots Oncology Organization

Examining the Current Role of Washington State Pharmacies in Pediatric Immunizations

NCODA National Monthly Webinar

NCODA Nursing Committee

Oncology Pharmacy Technician Association (OPTA)

Positive Quality Interventions: Idea to Implementation

Growth of NCODA Professional Student Organization Chapters

Positive Quality Interventions in Action

NCODA Patient Satisfaction Survey within Medically Integrated Dispensing Practices

Introduction to Utilization of Positive Quality Interventions and Treatment Support Kits with Selinexor

Treatment Support Kits: Supportive Care Provided for Patients

Real-World PARP Inhibitor Utilization Within the Recurrent Platinum-Sensitive Ovarian Cancer Population

Predictors of Hypomethylating Agent Discontinuation Among Patients With Higher-Risk Myelodysplastic Syndromes

Hospitalization and Emergency Room Visits Among Patients With Higher-Risk Myelodysplastic Syndromes by Hypomethylating Agent Use

Oncology Educational Exposure in the Top 20 U.S. Pharmacy Schools

Oral Chemo Parity Status in the United States

Interprofessional Collaboration to Develop Patient Educational Tools for Oral Oncolytics

A Pharmacist’s Role in Oral Oncolytics

The Pharmacist’s Role in Combating Polypharmacy: A Focus on Geriatric Oncology

Evaluation of WHO Listed Essential Medicines for Hematology & Oncology Registered In Botswana

Quality Measure Concepts to Fill Gaps in Oral Oncolytic Adherence: A Multi-Stakeholder Workgroup-Identified Measurement Strategy

Safety, Integrity, and Financial Risks of Oncology Dispensing Requirements in “Bagging” Practice

Tumor Lysis Syndrome Risk Analysis in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network

Use of Gold Nanoparticles in Photodynamic Therapy for the Treatment of Cancer

SPRING FORUM 2022

5-FU Induced Hyperammonemic Encephalopathy

7 Clinical Perspective- Ribociclib Overall Survival Benefit and Management Strategies, Including Mobile Technologies

A Pandemic’s Influence on Cancer Screening Rates for Adults in the United States

A successful model of biosimilar adoption in a community oncology practice

A treatment journey to remission: a case report of a cholangiocarcinoma patient treated with surgery, adjuvant and palliative chemotherapy, orthotropic liver transplantation, radiotherapy; a journey from despair to hope

Access to Bedside Hydration and Hydration status among Oncology in-patients- A Quality improvement Project

BURDEN OF CHEMOTHERAPY-INDUCED MYELOSUPPRESSION AMONG PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER- A RETROSPECTIVE STUDY OF DATA FROM COMMUNITY ONCOLOGY PRACTICES

BURDEN OF MYELOSUPPRESSION AMONG PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER TREATED WITH CHEMOTHERAPY IN A COMMUNITY ONCOLOGY SETTING

Cabazitaxel Cost Consequence Poster ESMO2021

Cannabinoids and weight management in oncology

Compliance of Letermovir Prescribing at a London Oncology Referral Hospital

DPYD Testing to Prevent Severe Fluoropyrimidine Chemotherapy Toxicity

Financial Toxicity

Hand Foot Syndrome vs Hand Foot Skin Reaction

Implementation of Guidelines Concordant Treatment Options in Patients with HR (Hormone Receptor Positive) and HER 2 neu Negative Advanced Breast Cancer

Importance of Smoking Cessation in Oncology Care

Improving Care Coordination for Patients on Oral Oncolytic Therapy

Leptomeningeal Involvement in CLL Treated with Ibrutinib

Multi-locus Inherited Neoplasia Alleles Syndrome (MINAS) with Birt-Hogg-Dube Syndrome (BHG) and Li-Fraumeni Syndrome (LFS)- Case

NCCN- ASCO NCODA Standards SF2022

NCODA CAWT SF2022pdf

NCODA CoE MIP SF2022

NCODA GROWTH SF2022

NCODA International Webinar SF2022

NCODA Nursing Committee SF2022

NCODA OPTA SF2022

NCODA Positive Quality Interventions (PQI) SF2022

NCODA PQI in Action SF2022

NCODA PSO SF2022

NCODA Selinexor Project Concept Poster SF2022

NCODA TSK SF2022

Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients With FGFR2 Fusions_Rearrangements

Precision Medicine- A Pinnacle of Innovation or a Pitfall of Explicit and Implicit Biases

Real World Outcomes Among Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors versus Immunotherapy or Chemotherapy in First line Setting

Real World Treatment Patterns of Metastatic Non Small Cell Lung Cancer (mNSCLC) Patients Receiving Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs)

The Role of Precision Medicine in Lung Cancer- Case Study and Review of Literature

Treatment Utilization and Characteristics Among Patients With Higher-Risk Myelodysplastic Syndromes According to Hypomethylating Agent Use

Use of Gold Nanoparticles in Photodynamic Therapy for the Treatment of Cancer

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

JOIN NCODA

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization